The American Society of Gene Therapy informs the media and public about new developments in gene therapy and gene therapy research through position statements. Following are links to recent ASGT position statements.

• ASGT Position Statement on Informed Consent (August 2008)
  
  
• NIH Funding of Gene Therapy Trials (September 29, 2006)
  
  
• ASGT Response to FDA Critical Path Statement (July 2004)
  
  
• Report from the ASGT Ad Hoc Committee on Retroviral-mediated Gene Transfer to Hematopoietic Stem Cells (April, 2003)
  
  
• Policy of The American Society of Gene Therapy on Financial Conflict of Interest in Clinical Research (Adopted April 15, 2000)
  
  

• Reporting of Patient Adverse Events in Gene Therapy Trials: Statement from the American Society of Gene Therapy
  (Adopted December 14, 1999)